Richer insights with adaptive sampling: targeted panels without probes for cancer predisposition, tumor profiling and beyond

Oxford Nanopore's digital panel technology is transforming clinical and translational cancer research, providing probe-free, long-read targeted panels that enable the detection of all variant classes, and methylation in a single, rapid assay.

From inherited cancer risk to tumor profiling and pharmacogenomics, this on-demand webinar presents Oxford Nanopore's off-the-shelf solutions for creating simple, rapid custom panels providing data-rich scalable insights into cancer biology.

In this webinar:

• Discover how Oxford Nanopore’s hereditary cancer panel uses long-read sequencing to identify all variant classes — SNVs, indels, structural variants, and methylation — in one streamlined workflow, without the need for separate enrichment or bisulfite steps.
• Learn how digital panels, powered by adaptive sampling, dynamically enriches for regions of interest in real time — offering flexible, probe-free target selection and the ability to customize or update panels instantly as research needs evolve.
• Explore how Oxford Nanopore’s technology supports a full continuum of cancer research — from hereditary cancer risk assessment to somatic mutation and pharmacogenomic profiling — with rapid, scalable, and data-rich insights for translational and clinical applications.